A 0 1 0 1 O
bone 2 6 2 6 B-treatment
marrow 7 13 7 13 I-treatment
biopsy 14 20 14 20 I-treatment
must 21 25 21 25 O
be 26 28 26 28 O
performed 29 38 29 38 O
within 39 45 39 45 O
four 46 50 46 50 B-upper_bound
weeks 51 56 51 56 I-upper_bound
prior 57 62 57 62 I-upper_bound
to 63 65 63 65 O
Cycle 66 71 66 71 O
1 72 73 72 73 O
Day 74 77 74 77 O
1 78 79 78 79 O
treatment 80 89 80 89 B-treatment
to 90 92 90 92 O
establish 93 102 93 102 O
the 103 106 103 106 O
baseline 107 115 107 115 O
fibrosis 116 124 116 124 B-clinical_variable
score 125 130 125 130 I-clinical_variable
, 130 131 130 131 O
and 132 135 132 135 O
consent 136 143 136 143 O
is 144 146 144 146 O
required 147 155 147 155 O
prior 156 161 156 161 O
to 162 164 162 164 O
that 165 169 165 169 O
bone 170 174 170 174 O
marrow 175 181 175 181 O
biopsy 182 188 182 188 O
to 189 191 189 191 O
assure 192 198 192 198 O
tissue 199 205 199 205 O
is 206 208 206 208 O
collected 209 218 209 218 O
for 219 222 219 222 O
protocol 223 231 223 231 O
mandated 232 240 232 240 O
testing 241 248 241 248 O

ANC 0 3 249 252 B-clinical_variable
≥ 4 5 253 254 O
750 6 9 255 258 B-lower_bound
/ 9 10 258 259 I-lower_bound
uL 10 12 259 261 I-lower_bound

After 0 5 262 267 O
discussion 6 16 268 278 O
with 17 21 279 283 O
the 22 25 284 287 O
study 26 31 288 293 O
chair 32 37 294 299 O
or 38 40 300 302 O
designee 41 49 303 311 O
, 49 50 311 312 O
patients 51 59 313 321 O
with 60 64 322 326 O
suboptimal 65 75 327 337 O
response 76 84 338 346 O
on 85 87 347 349 O
at 88 90 350 352 O
least 91 96 353 358 O
8 97 98 359 360 B-lower_bound
weeks 99 104 361 366 I-lower_bound
of 105 107 367 369 O
a 108 109 370 371 O
steady 110 116 372 378 O
dose 117 121 379 383 O
of 122 124 384 386 O
ruxolitinib 125 136 387 398 B-treatment
may 137 140 399 402 O
be 141 143 403 405 O
allowed 144 151 406 413 O
to 152 154 414 416 O
de 155 157 417 419 O
- 157 158 419 420 O
escalate 158 166 420 428 O
ruxolitinib 167 178 429 440 B-treatment
therapy 179 186 441 448 I-treatment
in 187 189 449 451 O
order 190 195 452 457 O
to 196 198 458 460 O
enter 199 204 461 466 O
a 205 206 467 468 O
safety 207 213 469 475 O
cohort 214 220 476 482 O
which 221 226 483 488 O
is 227 229 489 491 O
enrolling 230 239 492 501 O
patients 240 248 502 510 O
at 249 251 511 513 O
a 252 253 514 515 O
lower 254 259 516 521 O
dose 260 264 522 526 O

Allogeneic 0 10 527 537 B-treatment
stem 11 15 538 542 I-treatment
cell 16 20 543 547 I-treatment
transplant 21 31 548 558 I-treatment
within 32 38 559 565 O
6 39 40 566 567 B-upper_bound
months 41 47 568 574 I-upper_bound

Any 0 3 575 578 O
major 4 9 579 584 B-treatment
surgery 10 17 585 592 I-treatment
, 17 18 592 593 O
chemotherapy 19 31 594 606 B-treatment
, 31 32 606 607 O
or 33 35 608 610 O
immunotherapy 36 49 611 624 B-treatment
within 50 56 625 631 O
the 57 60 632 635 O
last 61 65 636 640 B-upper_bound
21 66 68 641 643 I-upper_bound
days 69 73 644 648 I-upper_bound
( 74 75 649 650 O
limited 75 82 650 657 O
palliative 83 93 658 668 B-treatment
radiation 94 103 669 678 I-treatment
is 104 106 679 681 O
allowed 107 114 682 689 O
≥ 115 116 690 691 O
2 117 118 692 693 B-lower_bound
weeks 119 124 694 699 I-lower_bound
) 124 125 699 700 O

Any 0 3 701 704 O
serious 4 11 705 712 O
, 11 12 712 713 O
unstable 13 21 714 722 O
medical 22 29 723 730 B-chronic_disease
or 30 32 731 733 O
psychiatric 33 44 734 745 B-chronic_disease
condition 45 54 746 755 I-chronic_disease
that 55 59 756 760 O
would 60 65 761 766 O
prevent 66 73 767 774 O
, 73 74 774 775 O
( 75 76 776 777 O
as 76 78 777 779 O
judged 79 85 780 786 O
by 86 88 787 789 O
the 89 92 790 793 O
Investigator 93 105 794 806 O
) 105 106 806 807 O
the 107 110 808 811 O
subject 111 118 812 819 O
properly 119 127 820 828 O
providing 128 137 829 838 O
informed 138 146 839 847 O
consent 147 154 848 855 O
or 155 157 856 858 O
any 158 161 859 862 O
condition 162 171 863 872 O
which 172 177 873 878 O
would 178 183 879 884 O
jeopardize 184 194 885 895 O
compliance 195 205 896 906 O
with 206 210 907 911 O
the 211 214 912 915 O
protocol 215 223 916 924 O

Autologous 0 10 925 935 B-clinical_variable
hematologic 11 22 936 947 I-clinical_variable
stem 23 27 948 952 I-clinical_variable
cell 28 32 953 957 I-clinical_variable
transplant 33 43 958 968 I-clinical_variable
within 44 50 969 975 O
3 51 52 976 977 B-upper_bound
months 53 59 978 984 I-upper_bound
of 60 62 985 987 O
study 63 68 988 993 O
entry 69 74 994 999 O

DCIS 0 4 1000 1004 B-cancer

Escalation 0 10 1005 1015 O
Stage 11 16 1016 1021 O
1 17 18 1022 1023 O
patients 19 27 1024 1032 O
: 27 28 1032 1033 O
who 29 32 1034 1037 O
have 33 37 1038 1042 O
not 38 41 1043 1046 O
achieved 42 50 1047 1055 O
normalization 51 64 1056 1069 O
of 65 67 1070 1072 O
splenomegaly 68 80 1073 1085 B-chronic_disease
, 80 81 1085 1086 O
symptomology 82 94 1087 1099 O
, 94 95 1099 1100 O
or 96 98 1101 1103 O
blood 99 104 1104 1109 O
counts 105 111 1110 1116 O
with 112 116 1117 1121 O
at 117 119 1122 1124 O
least 120 125 1125 1130 O
8 126 127 1131 1132 B-lower_bound
weeks 128 133 1133 1138 I-lower_bound
therapy 134 141 1139 1146 B-treatment
with 142 146 1147 1151 I-treatment
a 147 148 1152 1153 I-treatment
steady 149 155 1154 1160 I-treatment
dose 156 160 1161 1165 I-treatment
of 161 163 1166 1168 I-treatment
ruxolitinib 164 175 1169 1180 I-treatment

Escalation 0 10 1181 1191 O
Stage 11 16 1192 1197 O
2 17 18 1198 1199 O
: 18 19 1199 1200 O
patients 20 28 1201 1209 O
who 29 32 1210 1213 O
have 33 37 1214 1218 O
not 38 41 1219 1222 O
yet 42 45 1223 1226 O
received 46 54 1227 1235 O
therapy 55 62 1236 1243 B-treatment
with 63 67 1244 1248 I-treatment
any 68 71 1249 1252 I-treatment
JAK 72 75 1253 1256 I-treatment
- 75 76 1256 1257 I-treatment
STAT 76 80 1257 1261 I-treatment
inhibitory 81 91 1262 1272 I-treatment
agents 92 98 1273 1279 I-treatment
or 99 101 1280 1282 O
patients 102 110 1283 1291 O
on 111 113 1292 1294 O
at 114 116 1295 1297 O
least 117 122 1298 1303 O
8 123 124 1304 1305 B-lower_bound
weeks 125 130 1306 1311 I-lower_bound
of 131 133 1312 1314 O
a 134 135 1315 1316 O
steady 136 142 1317 1323 O
dose 143 147 1324 1328 O
of 148 150 1329 1331 O
ruxolitinib 151 162 1332 1343 B-treatment

For 0 3 1344 1347 O
escalation 4 14 1348 1358 O
, 14 15 1358 1359 O
subjects 16 24 1360 1368 O
must 25 29 1369 1373 O
have 30 34 1374 1378 O
a 35 36 1379 1380 O
pathologically 37 51 1381 1395 O
confirmed 52 61 1396 1405 O
diagnosis 62 71 1406 1415 O
of 72 74 1416 1418 O
PPV 75 78 1419 1422 B-cancer
- 78 79 1422 1423 I-cancer
MF 79 81 1423 1425 I-cancer
, 81 82 1425 1426 O
PETMF 83 88 1427 1432 B-cancer
, 88 89 1432 1433 O
or 90 92 1434 1436 O
PMF 93 96 1437 1440 B-cancer
as 97 99 1441 1443 O
per 100 103 1444 1447 O
the 104 107 1448 1451 O
EHA 108 111 1452 1455 O
or 112 114 1456 1458 O
WHO 115 118 1459 1462 O
diagnostic 119 129 1463 1473 O
criteria 130 138 1474 1482 O
( 139 140 1483 1484 O
see 140 143 1484 1487 O
Appendix 144 152 1488 1496 O
B 153 154 1497 1498 O
) 154 155 1498 1499 O
( 156 157 1500 1501 O
note 157 161 1501 1505 O
that 162 166 1506 1510 O
all 167 170 1511 1514 O
diagnoses 171 180 1515 1524 O
must 181 185 1525 1529 O
include 186 193 1530 1537 O
the 194 197 1538 1541 O
presence 198 206 1542 1550 O
of 207 209 1551 1553 O
at 210 212 1554 1556 O
least 213 218 1557 1562 O
Grade 219 224 1563 1568 B-lower_bound
1 225 226 1569 1570 I-lower_bound
marrow 227 233 1571 1577 O
fibrosis 234 242 1578 1586 O
according 243 252 1587 1596 O
to 253 255 1597 1599 O
the 256 259 1600 1603 O
European 260 268 1604 1612 B-clinical_variable
Consensus 269 278 1613 1622 I-clinical_variable
on 279 281 1623 1625 I-clinical_variable
Grading 282 289 1626 1633 I-clinical_variable
of 290 292 1634 1636 I-clinical_variable
BM 293 295 1637 1639 I-clinical_variable
Fibrosis 296 304 1640 1648 I-clinical_variable
as 305 307 1649 1651 O
well 308 312 1652 1656 O
as 313 315 1657 1659 O
int-1 316 321 1660 1665 O
, 321 322 1665 1666 O
int-2 323 328 1667 1672 O
, 328 329 1672 1673 O
or 330 332 1674 1676 O
high 333 337 1677 1681 O
risk 338 342 1682 1686 O
disease 343 350 1687 1694 O
according 351 360 1695 1704 O
to 361 363 1705 1707 O
the 364 367 1708 1711 O
IWG 368 371 1712 1715 O
- 371 372 1715 1716 O
MRT 372 375 1716 1719 O
Dynamic 376 383 1720 1727 O
IPSS 384 388 1728 1732 O

For 0 3 1733 1736 O
expansion 4 13 1737 1746 O
, 13 14 1746 1747 O
subjects 15 23 1748 1756 O
may 24 27 1757 1760 O
have 28 32 1761 1765 O
a 33 34 1766 1767 O
pathologically 35 49 1768 1782 O
confirmed 50 59 1783 1792 O
diagnosis 60 69 1793 1802 O
of 70 72 1803 1805 O
MF 73 75 1806 1808 B-chronic_disease
or 76 78 1809 1811 O
PV 79 81 1812 1814 B-chronic_disease
as 82 84 1815 1817 O
noted 85 90 1818 1823 O
above 91 96 1824 1829 O
in 97 99 1830 1832 O
# 100 101 1833 1834 O
2 101 102 1834 1835 O

Grade 0 5 1836 1841 B-lower_bound
II 6 8 1842 1844 I-lower_bound
, 8 9 1844 1845 O
or 10 12 1846 1848 O
greater 13 20 1849 1856 O
, 20 21 1856 1857 O
active 22 28 1858 1864 O
graft 29 34 1865 1870 B-chronic_disease
versus 35 41 1871 1877 I-chronic_disease
- 41 42 1877 1878 I-chronic_disease
host 42 46 1878 1882 I-chronic_disease
disease 47 54 1883 1890 I-chronic_disease

Hgb 0 3 1891 1894 B-clinical_variable
≥ 4 5 1895 1896 O
8 6 7 1897 1898 B-lower_bound
g 8 9 1899 1900 I-lower_bound
/ 9 10 1900 1901 I-lower_bound
dL 10 12 1901 1903 I-lower_bound

History 0 7 1904 1911 O
of 8 10 1912 1914 O
cerebral 11 19 1915 1923 B-chronic_disease
vascular 20 28 1924 1932 I-chronic_disease
accident 29 37 1933 1941 I-chronic_disease
, 37 38 1941 1942 O
unstable 39 47 1943 1951 B-chronic_disease
angina 48 54 1952 1958 I-chronic_disease
, 54 55 1958 1959 O
myocardial 56 66 1960 1970 B-chronic_disease
infarction 67 77 1971 1981 I-chronic_disease
, 77 78 1981 1982 O
or 79 81 1983 1985 O
ventricular 82 93 1986 1997 B-chronic_disease
arrhythmia 94 104 1998 2008 I-chronic_disease
within 105 111 2009 2015 O
the 112 115 2016 2019 O
last 116 120 2020 2024 B-upper_bound
6 121 122 2025 2026 I-upper_bound
months 123 129 2027 2033 I-upper_bound

Known 0 5 2034 2039 O
history 6 13 2040 2047 O
of 14 16 2048 2050 O
human 17 22 2051 2056 B-chronic_disease
immunodeficiency 23 39 2057 2073 I-chronic_disease
virus 40 45 2074 2079 I-chronic_disease
( 46 47 2080 2081 I-chronic_disease
HIV 47 50 2081 2084 I-chronic_disease
) 50 51 2084 2085 I-chronic_disease

Life 0 4 2086 2090 B-clinical_variable
expectancy 5 15 2091 2101 I-clinical_variable
of 16 18 2102 2104 O
at 19 21 2105 2107 O
least 22 27 2108 2113 O
six 28 31 2114 2117 B-lower_bound
months 32 38 2118 2124 I-lower_bound

Ongoing 0 7 2125 2132 B-treatment
immunosuppressive 8 25 2133 2150 I-treatment
therapy 26 33 2151 2158 I-treatment
( 34 35 2159 2160 O
prednisone 35 45 2160 2170 B-treatment
or 46 48 2171 2173 O
equivalent 49 59 2174 2184 O
≤10 60 63 2185 2188 O
mg 64 66 2189 2191 I-upper_bound
daily 67 72 2192 2197 I-upper_bound
allowed 73 80 2198 2205 O
as 81 83 2206 2208 O
clinically 84 94 2209 2219 O
warranted 95 104 2220 2229 O
) 104 105 2229 2230 O

Organ 0 5 2231 2236 B-treatment
transplant 6 16 2237 2247 I-treatment
recipients 17 27 2248 2258 O

Other 0 5 2259 2264 O
invasive 6 14 2265 2273 O
malignancies 15 27 2274 2286 B-cancer
within 28 34 2287 2293 O
the 35 38 2294 2297 O
last 39 43 2298 2302 B-upper_bound
2 44 45 2303 2304 I-upper_bound
years 46 51 2305 2310 I-upper_bound

Patient 0 7 2311 2318 O
has 8 11 2319 2322 O
received 12 20 2323 2331 O
wide 21 25 2332 2336 B-treatment
field 26 31 2337 2342 I-treatment
radiotherapy 32 44 2343 2355 I-treatment
( 45 46 2356 2357 O
including 46 55 2357 2366 O
therapeutic 56 67 2367 2378 B-treatment
radioisotopes 68 81 2379 2392 I-treatment
such 82 86 2393 2397 I-treatment
as 87 89 2398 2400 I-treatment
strontium 90 99 2401 2410 I-treatment
89 100 102 2411 2413 I-treatment
) 102 103 2413 2414 O
≤ 104 105 2415 2416 O
28 106 108 2417 2419 B-upper_bound
days 109 113 2420 2424 I-upper_bound
or 114 116 2425 2427 O
limited 117 124 2428 2435 O
field 125 130 2436 2441 B-treatment
radiation 131 140 2442 2451 I-treatment
for 141 144 2452 2455 O
palliation 145 155 2456 2466 O
≤ 156 157 2467 2468 O
14 158 160 2469 2471 B-upper_bound
days 161 165 2472 2476 I-upper_bound
prior 166 171 2477 2482 I-upper_bound
to 172 174 2483 2485 O
starting 175 183 2486 2494 O
trial 184 189 2495 2500 O
medications 190 201 2501 2512 B-treatment
or 202 204 2513 2515 O
has 205 208 2516 2519 O
not 209 212 2520 2523 O
recovered 213 222 2524 2533 O
from 223 227 2534 2538 O
side 228 232 2539 2543 O
effects 233 240 2544 2551 O
of 241 243 2552 2554 O
such 244 248 2555 2559 O
therapy 249 256 2560 2567 O

Patients 0 8 2568 2576 O
with 9 13 2577 2581 O
these 14 19 2582 2587 O
diagnoses 20 29 2588 2597 O
may 30 33 2598 2601 O
be 34 36 2602 2604 O
eligible 37 45 2605 2613 O
, 45 46 2613 2614 O
provided 47 55 2615 2623 O
they 56 60 2624 2628 O
are 61 64 2629 2632 O
able 65 69 2633 2637 O
to 70 72 2638 2640 O
obtain 73 79 2641 2647 O
ruxolitinib 80 91 2648 2659 B-treatment
from 92 96 2660 2664 O
commercial 97 107 2665 2675 O
supply 108 114 2676 2682 O

Plt 0 3 2683 2686 B-clinical_variable
≥ 4 5 2687 2688 O
30k 6 9 2689 2692 B-lower_bound

Previous 0 8 2693 2701 B-treatment
therapy 9 16 2702 2709 I-treatment
with 17 21 2710 2714 I-treatment
GS-1101 22 29 2715 2722 I-treatment
( 30 31 2723 2724 O
CAL-101 31 38 2724 2731 B-treatment
) 38 39 2731 2732 O
, 39 40 2732 2733 O
IPI-145 41 48 2734 2741 B-treatment

Psychological 0 13 2742 2755 B-chronic_disease
, 13 14 2755 2756 O
familial 15 23 2757 2765 B-chronic_disease
, 23 24 2765 2766 O
sociological 25 37 2767 2779 B-chronic_disease
, 37 38 2779 2780 O
or 39 41 2781 2783 O
geographical 42 54 2784 2796 B-chronic_disease
conditions 55 65 2797 2807 I-chronic_disease
that 66 70 2808 2812 O
do 71 73 2813 2815 O
not 74 77 2816 2819 O
permit 78 84 2820 2826 O
compliance 85 95 2827 2837 O
with 96 100 2838 2842 O
the 101 104 2843 2846 O
protocol 105 113 2847 2855 O

Recovery 0 8 2856 2864 O
to 9 11 2865 2867 O
≤ 12 13 2868 2869 O
Grade 14 19 2870 2875 B-upper_bound
1 20 21 2876 2877 I-upper_bound
or 22 24 2878 2880 O
baseline 25 33 2881 2889 O
of 34 36 2890 2892 O
any 37 40 2893 2896 O
toxicities 41 51 2897 2907 O
due 52 55 2908 2911 O
to 56 58 2912 2914 O
prior 59 64 2915 2920 B-treatment
systemic 65 73 2921 2929 I-treatment
treatments 74 84 2930 2940 I-treatment

Subjects 0 8 2941 2949 O
must 9 13 2950 2954 O
have 14 18 2955 2959 O
an 19 21 2960 2962 O
Eastern 22 29 2963 2970 B-clinical_variable
Cooperative 30 41 2971 2982 I-clinical_variable
Oncology 42 50 2983 2991 I-clinical_variable
Group 51 56 2992 2997 I-clinical_variable
( 57 58 2998 2999 I-clinical_variable
ECOG 58 62 2999 3003 I-clinical_variable
) 62 63 3003 3004 I-clinical_variable
Performance 64 75 3005 3016 I-clinical_variable
Status 76 82 3017 3023 I-clinical_variable
of 83 85 3024 3026 O
0 86 87 3027 3028 B-lower_bound
- 87 88 3028 3029 O
2 88 89 3029 3030 B-upper_bound

There 0 5 3031 3036 O
are 6 9 3037 3040 O
also 10 14 3041 3045 O
two 15 18 3046 3049 O
expansion 19 28 3050 3059 O
cohorts 29 36 3060 3067 O
for 37 40 3068 3071 O
patients 41 49 3072 3080 O
with 50 54 3081 3085 O
MDS 55 58 3086 3089 B-cancer
/ 58 59 3089 3090 I-cancer
MPN 59 62 3090 3093 I-cancer
( 63 64 3094 3095 O
CMML 64 68 3095 3099 B-cancer
, 68 69 3099 3100 O
aCML 70 74 3101 3105 B-cancer
, 74 75 3105 3106 O
RARS 76 80 3107 3111 B-chronic_disease
- 80 81 3111 3112 I-chronic_disease
T 81 82 3112 3113 I-chronic_disease
or 83 85 3114 3116 O
MDS 86 89 3117 3120 B-cancer
/ 89 90 3120 3121 I-cancer
MPN 90 93 3121 3124 I-cancer
- 93 94 3124 3125 I-cancer
U 94 95 3125 3126 I-cancer
) 95 96 3126 3127 O
which 97 102 3128 3133 O
warrants 103 111 3134 3142 O
treatment 112 121 3143 3152 B-treatment

Use 0 3 3153 3156 O
of 4 6 3157 3159 O
an 7 9 3160 3162 O
investigational 10 25 3163 3178 B-treatment
drug 26 30 3179 3183 I-treatment
within 31 37 3184 3190 O
21 38 40 3191 3193 B-upper_bound
days 41 45 3194 3198 I-upper_bound
or 46 48 3199 3201 O
5 49 50 3202 3203 B-lower_bound
half 51 55 3204 3208 I-lower_bound
- 55 56 3208 3209 I-lower_bound
lives 56 61 3209 3214 I-lower_bound
( 62 63 3215 3216 O
whichever 63 72 3216 3225 O
is 73 75 3226 3228 O
shorter 76 83 3229 3236 O
) 83 84 3236 3237 O
prior 85 90 3238 3243 B-treatment
to 91 93 3244 3246 I-treatment
the 94 97 3247 3250 I-treatment
first 98 103 3251 3256 I-treatment
dose 104 108 3257 3261 I-treatment
of 109 111 3262 3264 I-treatment
TGR-1202 112 120 3265 3273 I-treatment

Women 0 5 3274 3279 B-gender
who 6 9 3280 3283 O
are 10 13 3284 3287 B-pregnancy
pregnant 14 22 3288 3296 I-pregnancy

alopecia 0 8 3297 3305 B-chronic_disease

any 0 3 3306 3309 O
drug 4 8 3310 3314 O
that 9 13 3315 3319 O
specifically 14 26 3320 3332 O
inhibits 27 35 3333 3341 O
PI3 36 39 3342 3345 B-treatment
K 39 40 3345 3346 I-treatment
or 41 43 3347 3349 O
mTOR 44 48 3350 3354 B-treatment
within 49 55 3355 3361 O
last 56 60 3362 3366 B-upper_bound
6 61 62 3367 3368 I-upper_bound
months 63 69 3369 3375 I-upper_bound

bone 0 4 3376 3380 B-treatment
marrow 5 11 3381 3387 I-treatment
transplant 12 22 3388 3398 I-treatment

cervical 0 8 3399 3407 B-cancer
cancer 9 15 3408 3414 I-cancer

hepatitis 0 9 3415 3424 B-chronic_disease
B 10 11 3425 3426 I-chronic_disease
carriers 12 20 3427 3435 O
with 21 25 3436 3440 O
normal 26 32 3441 3447 O
LFTs 33 37 3448 3452 B-clinical_variable
and 38 41 3453 3456 O
undetectable 42 54 3457 3469 O
viral 55 60 3470 3475 O
loads 61 66 3476 3481 O

known 0 5 3482 3487 O
active 6 12 3488 3494 B-chronic_disease
hepatitis 13 22 3495 3504 I-chronic_disease
A 23 24 3505 3506 I-chronic_disease
, 24 25 3506 3507 I-chronic_disease
B 26 27 3508 3509 I-chronic_disease
, 27 28 3509 3510 I-chronic_disease
or 29 31 3511 3513 I-chronic_disease
C 32 33 3514 3515 I-chronic_disease
infection 34 43 3516 3525 I-chronic_disease

non 0 3 3526 3529 B-cancer
- 3 4 3529 3530 I-cancer
melanoma 4 12 3530 3538 I-cancer
skin 13 17 3539 3543 I-cancer
cancer 18 24 3544 3550 I-cancer

patients 0 8 3551 3559 O
must 9 13 3560 3564 O
receive 14 21 3565 3572 O
the 22 25 3573 3576 O
lower 26 31 3577 3582 O
dose 32 36 3583 3587 O
of 37 39 3588 3590 O
ruxolitinib 40 51 3591 3602 B-treatment
for 52 55 3603 3606 O
at 56 58 3607 3609 O
least 59 64 3610 3615 O
7 65 66 3616 3617 B-lower_bound
consecutive 67 78 3618 3629 I-lower_bound
days 79 83 3630 3634 I-lower_bound
without 84 91 3635 3642 O
event 92 97 3643 3648 O
before 98 104 3649 3655 O
adding 105 111 3656 3662 O
TGR-1202 112 120 3663 3671 B-treatment

patients 0 8 3672 3680 O
with 9 13 3681 3685 O
exposure 14 22 3686 3694 O
to 23 25 3695 3697 O
other 26 31 3698 3703 B-treatment
JAK 32 35 3704 3707 I-treatment
- 35 36 3707 3708 I-treatment
STAT 36 40 3708 3712 I-treatment
inhibitory 41 51 3713 3723 I-treatment
agents 52 58 3724 3730 I-treatment

use 0 3 3731 3734 O
topical 4 11 3735 3742 B-treatment
or 12 14 3743 3745 O
inhaled 15 22 3746 3753 B-treatment
corticosteroids 23 38 3754 3769 I-treatment

